CONTACT INFORMATION http://www.loyola.org
Tulio Rodriguez
M.D.
  • Associate Professor
  • Medical Director, Bone Marrow Transplantation
  • Hematology/Oncology
Specialties
Non-Hodgkin's Lymphoma, Stem Cell/Bone Marrow Transplant, Multiple Myeloma, Monoclonal Gammopathies, Blood Disorders, Leukemia
Board Certifications
  • Hematology - Subspecialty Cert: AM Board of Internal Medicine
  • Internal Medicine - General Cert: AM Board of Internal Medicine
Publications

Safety and Efficacy of Targeted-Dose Busulfan and Bortezomib as Conditioning Regimen for Patients with Relapsed Multiple Myeloma Undergoing a Second Autologous Blood Progenitor Cell TransplantFreytes,C. O.; Toro,J. J.; Yeh,R. F.; Stadtmauer,E. A.; Ratanatharathorn,V.; Akpek,G.; Sahovic,E.; Tricot,G. J.; Shaughnessy,P. J.; White,D. J.; Rodriguez,T. E.; Solomon,S. R.; Yu,L. H.; Zhao,C.; Patil,S.; Armstrong,E.; Smith,A.; Elekes,A.; Kato,K.; Reece,D. E.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2014 ; ( ):

Seven-year follow-up of allogeneic transplant using BCNU, etoposide, cytarabine and melphalan chemotherapy in patients with Hodgkin lymphoma after autograft failure: importance of minimal residual diseaseSobol,U.; Rodriguez,T.; Smith,S.; Go,A.; Vimr,R.; Parthasarathy,M.; Guo,R.; Stiff,P.Leukemia & lymphoma 2014 ;55(6):1281-1287

Prevention of nausea and vomiting associated with stem cell transplant: results of a prospective, randomized trial of aprepitant used with highly emetogenic preparative regimensStiff,P. J.; Fox-Geiman,M. P.; Kiley,K.; Rychlik,K.; Parthasarathy,M.; Fletcher-Gonzalez,D.; Porter,N.; Go,A.; Smith,S. E.; Rodriguez,T. E.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013 ;19(1):49-55.e1

Clostridium difficile infection and limitations of markers for severity in patients with hematologic malignancyWang,M. S.; Evans,C. T.; Rodriguez,T.; Gerding,D. N.; Johnson,S.Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2013 ;34(2):127-132

TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomesChoi,S. W.; Stiff,P.; Cooke,K.; Ferrara,J. L.; Braun,T.; Kitko,C.; Reddy,P.; Yanik,G.; Mineishi,S.; Paczesny,S.; Hanauer,D.; Pawarode,A.; Peres,E.; Rodriguez,T.; Smith,S.; Levine,J. E.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012 ;18(10):1525-1532

The impact of pharmacotherapy on depression and quality of life in patients undergoing a bone marrow transplant (BMT).Mumby,P. B.; Garcia,C.; Trivedi-Purohit,R.; Gourvitz,R.; Rychlik,K.; Rodriguez,T.; Smith,S. E.; Toor,A. A.; Rao,M.; Stiff,P. J.ASCO Meeting Abstracts 2010 ;28(15_suppl):9132

Randomized phase III trial of pegfilgrastim versus filgrastim after autologus peripheral blood stem cell transplantation.Gerds,A.; Fox-Geiman,M.; Dawravoo,K.; Rodriguez,T.; Toor,A.; Smith,S.; Kiley,K.; Fletcher-Gonzalez,D.; Hicks,C.; Stiff,P.Biology of Blood & Marrow Transplantation 2010 ;16(5):678-685

Feasibility of conditioning with thymoglobulin and reduced intensity TBI to reduce acute GVHD in recipients of allogeneic SCTToor,A.; Rodriguez,T.; Bauml,M.; Mathews,H.; Shanti,S.; Senitzer,D.; Kini,A.; Norton,J.; Parthasarathy,M.; Mohideen,N.; Petrowsky,C.; Bonilla,B.; Smith,S.; Stiff,P.Bone marrow transplantation 2008 ;42(11):723-731

Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections.Mullane,K.; Toor,A. A.; Kalnicky,C.; Rodriguez,T.; Klein,J.; Stiff,P.Transplant Infectious Disease 2007 ;9(2):89-96

Alefacept in corticosteroid refractory graft versus host disease: early results indicate promising activityToor,A. A.; Stiff,P. J.; Nickoloff,B. J.; Rodriguez,T.; Klein,J. L.; Gordon,K. B.The Journal of dermatological treatment 2007 ;18(1):13-18

The administration of polymerized human hemoglobin (Pyridoxylated) to a Jehovah's Witness after submyeloablative stem cell transplantation complicated by delayed graft failureSmith,S. E.; Toor,A.; Rodriguez,T.; Stiff,P.Comprehensive therapy 2006 ;32(3):172-175

Autologous hematopoietic stem cell transplants that utilize total body irradiation can safely be carried out entirely on an outpatient basisStiff,P.; Mumby,P.; Miler,L.; Rodriguez,T.; Parthswarthy,M.; Kiley,K.; Porter,N.; Batiste,R.; Wojtowitz,S.; Lichtenstein,S.; Fox-Geiman,M.; Toor,A.Bone marrow transplantation 2006 ;38(11):757-764

Patients' understanding of disease status and treatment plan at initial hematopoietic stem cell transplantation consultation.Stiff,P. J.; Miller,L. A.; Mumby,P.; Kiley,K.; Batiste,R.; Porter,N.; Potocki,K.; Volle,M.; Lichtenstein,S.; Wojtowicz,S.; Zakrzewski,S.; Toor,A.; Rodriguez,T.Bone marrow transplantation 2006 ;37(5):479-484

Second allografts for relapsed hematologic malignancies: feasibility of using a different donor.Duus,J. E.; Stiff,P. J.; Choi,J.; Parthasarathy,M.; Rodriguez,T.; Toor,A. A.Bone marrow transplantation 2005 ;35(3):261-264

Favourable results with a single autologous stem cell transplant following conditioning with busulphan and cyclophosphamide in patients with multiple myelomaToor,A. A.; Ayers,J.; Strupeck,J.; Parthasarathy,M.; Creech,S.; Rodriguez,T.; Stiff,P. J.British journal of haematology 2004 ;124(6):769-776

Current treatment results of allogeneic bone marrow transplantation for acute myeloid and lymphoid leukemiaRodriguez,T. E.; Stiff,P. J.Current Hematology Reports 2003 ;2(4):295-301

Education
Medical School
  • Pontificia Universidad Catolica Madre y Maestra School of Medicine
Residency
  • VA Medical Center, San Juan, Internal Medicine: General
Fellowship
  • University of Texas Health Science Center, San Antonio, Hematology/Oncology
  • University of Texas Health Science Center, San Antonio, Bone Marrow Transplantation
Languages
  • Spanish
Interests
  • Jazz and Latin Music